DESCRIPTION
An 81-year-old gentleman was urgently referred to clinic with a 2-week history of swelling of his face and arms (figure 1). He was not breathless and no other symptoms were elicited on history taking. He was previously well with the exception of osteoarthritis for which he took paracetamol only. He had smoked roll-up cigarettes for many years using up to 100 g of tobacco per week. There was no history of asbestos exposure.
Physical examination was consistent with superior vena cava obstruction (SVCO) with a fixed raised internal jugular vein, swollen face, arms and prominent superficial veins throughout his chest wall. He was not clubbed and had no palpable lymphadenopathy. He was sent for a chest radiograph (CXR) (figure 2). A clinical diagnosis of SVCO was made and a CT scan of the neck and thorax was arranged.
The CXR (figure 2) showed an apparent widening of the superior mediastinum due to unfolding of the aorta. No soft tissue lesion was seen in the paratracheal region and the SVC contour appeared normal. Figure 3 shows an axial CT image from a postintravenous contrast scan and demonstrates the presence of abnormal anterior mediastinal soft tissue (white arrows). The SVC is of increased calibre and obstructed by a filling defect (black arrow). The tumour tissue in the anterior mediastinum was thought not to contribute to the mediastinal silhouette on his CXR (figure 2). Figure 4 is an oblique saggital CT image demonstrating a filling defect contiguous with that in the SVC extending via a tributary to the anterior medastinal soft tissue (black arrows).
The case was discussed in a multidisciplinary meeting and the patient went on to have an open mediastinal biopsy to confirm the diagnosis. This was performed through a minithoracotomy and demonstrated a type B2 thymoma on histological examination. His symptoms resolved with anticoagulation; however, he was considered too frail for any further intervention.
DISCUSSION
Tumour as the cause of SVCO is well recognised in primary lung cancer and lymphoma. Rarer tumour types causing SVCO are also frequently described in case series, although in the majority of cases external compression is the cause. Direct tumour invasion into the SVC is far more rare. 1 Thymomas, although rare, are the most common tumours of the anterior mediastinum with an incidence of 0.15/100 000. 2 As many as 34% invade through their own capsule but lymphogenous and haematogenous Figure 1 Photograph of the patient demonstrating arm swelling and extensive chest wall collateral vessels. Figure 2 Chest radiograph.
spread are unusual. 2 Management and prognosis are dependent on stage and the Masaoka clinical staging system is the most often used. 2 Treatment may involve surgical resection or debulking with or without adjuvant radiotherapy; chemotherapy may be given in adjuvant or neoadjuvant regimes.
3 Five-year survival ranges between 96% and 100% for stage 1 disease and 11-50% for stage 4a. 2 In those who present with clinical SVCO crosssectional imaging is almost always requested to ascertain the nature of its cause. Causes include an obstructing mass (which may or may not be identifiable on CXR) stenosis of the SVC and, as in this case, tumour thrombus. Tumour thrombus is an important differential to consider since anticoagulation may be of therapeutic benefit. An SVC venogram with contrast injection via both arms will delineate any thrombus; injection via one arm introduces an artifactual filling defect in the SVC due to mixing of contrast enhanced flow with uncontrasted blood from the contralateral arm. Post-intravenous contrast CT, again ideally with contrast injection via both arms, provides more information regarding the possible causes of SVCO than a non-enhanced scan or a scan with contrast injected unilaterally. We suggest that, in cases of clinical SVCO, clinicians should consider the diagnosis of tumour thrombus and, if there is a suspicion, should request a postintravenous contrast CT scan with contrast injection via both arms. If diagnosed, the symptoms of SVCO may improve with anticoagulation which is particularly important for those who are unlikely to be offered any surgical or oncological intervention. 
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